ONS-5010 (bevacizumab-vikg) was found to be noninferior to ranibizumab for neovascular age-related macular degeneration at week 12.

Tailoring your e-mail to the recipient is essential. According to the survey, 58% of hiring managers are most likely to ...

Personal statements have sometimes been criticised for lacking structure or guidance for students, so we’ve taken a look at what the admissions team at highly-ranked Edge Hill University looks for in ...